- FDA approves Regeneron’s hearing loss gene therapyOtarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s “national priority” voucher program and will be offered to eligible patients…BioPharma Dive · 3mo ago↗ source
- FDA approves Regeneron's hearing loss gene therapy OtarmeniRegeneron has won the first-ever FDA approval for a gene therapy to treat a rare type of inherited hearing loss, and the company plans to offer the treatment for free in the US, though that ...Endpoints · 3mo ago↗ source
- Sanofi posts upbeat sales as R&D pressure buildsA string of research setbacks have left the pharmaceutical giant at a crossroads just as a new CEO is set to take over. But positive first-quarter earnings provided the company with a needed boost.